Related Experiment Video
Updated: Jul 9, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Hyperlipidemia in chronic kidney disease.
1Division of Nephrology, Department of Medicine, University of California Davis, California 95616, USA. gakaysen@ucdavis.edu
The International Journal of Artificial Organs
|December 11, 2007
Summary
Cardiovascular risk factors change with declining kidney function. In dialysis patients, obesity improves survival, while altered cholesterol levels like low High Density Lipoprotein cholesterol (HDL) remain critical.
Area of Science:
- Nephrology
- Cardiology
- Lipidology
Background:
- Cardiovascular disease risk and mortality escalate with diminished renal function.
- Traditional cardiovascular risk factors are modified or superseded in patients with kidney disease.
- Obesity's impact shifts from predicting renal function loss to predicting survival in dialysis patients.
Purpose of the Study:
- To explore the altered cardiovascular risk profiles in patients with declining renal function and end-stage renal disease.
- To investigate the role of specific lipoproteins, including Low Density Lipoprotein cholesterol (LDL), High Density Lipoprotein cholesterol (HDL), and Intermediate Density Lipoproteins (IDL), in cardiovascular outcomes in kidney disease.
- To examine the mechanisms behind dyslipidemia in chronic kidney disease (CKD) and their association with mortality.
Main Methods:
- Analysis of established cardiovascular risk factors in the context of varying degrees of renal function.
- Evaluation of lipoprotein profiles (LDL, HDL, IDL, Lipoprotein (a)) and their correlation with mortality and survival in dialysis patients.
- Investigation of the impact of chronic kidney disease (CKD) on lipid metabolism, including fractional catabolic rate (FCR), lecithin cholesterol ester transfer protein (LCAT) activity, and insulin resistance.
Main Results:
- Obesity is linked to survival in dialysis patients, contrasting its role in renal function decline.
- Low HDL and increased IDL levels are significant cardiovascular risk factors in dialysis patients, whereas LDL is not.
- Dyslipidemia in CKD involves decreased HDL maturation, increased triglycerides (TG), and elevated Lipoprotein (a) (Lp(a)) due to reduced clearance, all associated with adverse cardiovascular outcomes.
Conclusions:
- Cardiovascular risk assessment in kidney disease requires a shift from standard models, focusing on specific lipid abnormalities.
- Altered HDL metabolism and increased TG-rich IDL and Lp(a) are key contributors to cardiovascular risk in CKD and dialysis patients.
- Understanding these unique pathophysiological mechanisms is crucial for managing cardiovascular complications in patients with impaired renal function.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...